EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS098-35380 
Organism
Homo sapiens 
Tissue/cell
HSMM 
Coordinate
chr20:62833300-62835150 
TF binding sites/motifs
Number: 22             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EN2MA0642.1chr20:62834647-62834657GCTAATTGGG-6.02
EWSR1-FLI1MA0149.1chr20:62834917-62834935CCCTCCTTCCCTCCCTCT-6.03
EWSR1-FLI1MA0149.1chr20:62834902-62834920TCTTCCCTCCTCCCTCCC-6.04
EWSR1-FLI1MA0149.1chr20:62833946-62833964AGAGGGAGGGAAGGCAGG+6.15
EWSR1-FLI1MA0149.1chr20:62833950-62833968GGAGGGAAGGCAGGGAAG+6.39
EWSR1-FLI1MA0149.1chr20:62834909-62834927TCCTCCCTCCCTCCTTCC-6.3
EWSR1-FLI1MA0149.1chr20:62834913-62834931CCCTCCCTCCTTCCCTCC-6.84
KLF4MA0039.3chr20:62834116-62834127CCACACCCTCT+6.02
Klf1MA0493.1chr20:62834114-62834125GGCCACACCCT+6.32
Myod1MA0499.1chr20:62834603-62834616AGCAGCTGTCACC+6.41
MyogMA0500.1chr20:62834602-62834613CAGCAGCTGTC-6.14
Tcf12MA0521.1chr20:62834602-62834613CAGCAGCTGTC-6.02
ZNF263MA0528.1chr20:62834851-62834872TCGCTCTCTCCCTCTTCCTCC-6.02
ZNF263MA0528.1chr20:62833947-62833968GAGGGAGGGAAGGCAGGGAAG+6.15
ZNF263MA0528.1chr20:62834860-62834881CCCTCTTCCTCCCTCTTCCCC-6.3
ZNF263MA0528.1chr20:62834901-62834922CTCTTCCCTCCTCCCTCCCTC-6.73
ZNF263MA0528.1chr20:62834897-62834918TTCCCTCTTCCCTCCTCCCTC-6.78
ZNF263MA0528.1chr20:62834866-62834887TCCTCCCTCTTCCCCTCCCTT-6.7
ZNF263MA0528.1chr20:62834909-62834930TCCTCCCTCCCTCCTTCCCTC-6.91
ZNF263MA0528.1chr20:62834913-62834934CCCTCCCTCCTTCCCTCCCTC-7.29
ZNF263MA0528.1chr20:62834854-62834875CTCTCTCCCTCTTCCTCCCTC-7.57
ZNF263MA0528.1chr20:62834905-62834926TCCCTCCTCCCTCCCTCCTTC-7.92
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_65388chr20:62833352-62837092Pancreatic_islets
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr206283405262834240
Number: 1             
IDChromosomeStartEnd
GH20I064202chr206283335362837092
Enhancer Sequence
CTGCGTGTCG GGAACCCCCG CGTGTCGGGA ACCCCCGCGT GTCGGGAACC CCCGCGTGTC 60
GGGAACCCCT CGCGTGTCGG GAACCCCCGC GTGTCGGGAA CCTCTGCGTG TCGGGAACCC 120
CTGTGTGCAG GACTTTCTCT GTGGATGACT TAACACTGCA TTGGCTCAGA ACTTCACAGC 180
CTGCAGTGCC CCTAACCCCA GCTCGCCTCC CCACCAGCTC AGGCAGAGCT CCCAGGAAGA 240
CAGTCCATTG GTTGTTTACC AGGTGAGCTG AGGAGAGGTT GGACTTGGAT CGAGCAGGAC 300
CCTGAGCTGC TATTTCCGAC CTCGGAGCCC ACTGGGAGTG CCTGAGCGAA GAAGCAGTTT 360
GATGGTTTTT CCTTTCACCC CATCGGGAGA ACTGATGACG TTTCAGCTTG TATTTTTGCC 420
TGGGTCCATC TGTTGTCACA TGGCCTCAGA CTGGCTCTGC CAGAGGCGAA GACTAGGGAA 480
GGTTAGGGTT GGGGTTAGCA TCTTTGAGAC AGCGAGGCGC TGACAACACC GAGTTCAGGA 540
CCATCTCCAA GTTCAGAGAG AGAACACGTC TGTAGCTCAC CCTTCTTCTT CTGGCGCCTT 600
CCTCCTTGAG CCACTGGCCA ACTCCCACCC AGATGACTGC CCCAGGAGAG GGAGGGAAGG 660
CAGGGAAGGC AGTGTCTTCA AAGGCTAGTA GCTGAAGCAT GGGGCTCCAG GCTGGGATTC 720
AGTTCCTCTC CTGACTTGTC TCCTTTGACG CCTACTTTTC AAGTTTGGGT CCCTCAGAGC 780
TGTCATGCAG GATGCCAGCT GAGGGGTGAC TGTGGGCCAC ACCCTCTTCC CAGCCTCACG 840
TGCATCCTTT CCTCACATCT CTGACACCAG CCCTAGTCAG AGCTGGGGAG TCAAGGCTGG 900
GGAATTCCCT CCTCCCGGAG AAAAGAGGCT CGGGAGTCCT GGAGCCCTGG CCGTCTTCCT 960
CTCCCTACAA CTCTGGCCCT GAGCACCCAG AGGACATCAG GAAATAAGAG CTGAGTGTGC 1020
TTGCAGGTGA ACTGCAGGGC TGGCATCTGC TGGCACGACA CCCTTGGAGG CCCTGGCTGG 1080
GTCTCTTGTC CACTCGGCTG TGGGGTGGGG AGCAGGCATC TAAGGGGTTT CCAGCTTCCT 1140
GTCCCCGAGC GGCCTTGTCC GCTCCACGCA CTTGGGCTCA CAGCCGTGTC TCACACCCTC 1200
TGAGGCTGGG GCCGGAAGGT GCAGGCCCAC CTTCCTGGGG ACCAGGACTC TTCTGAGCTG 1260
AGGGTGACGT GTTCAGGGCA GTCCGGTCCC CACAGGCCTC CACAGCAGCT GTCACCTAAT 1320
TGCCTGATTC ACTCAGTGAT GTCATCGGCT AATTGGGACC TTAGCTTCAA ATCCCCATTA 1380
ACAAGGAGCT TTTTTGTGAA AAGTCCCAAA GCTAGTTCTC CAAAGAGTGA AAGCAAGTGT 1440
GGGCCTGGAT TTTAGAAGAG ACTAGAGGCA GGGAGAGGTG GGTGGCAGCG GCGGCAACTC 1500
CCTCAGTTTG GAAAGGGAGC CCCCAGTCGA GTGTGGTGTG CCCTCCCTCT CTCGCTCTCT 1560
CCCTCTTCCT CCCTCTTCCC CTCCCTTCCC GTCTGGGTTC CCTCTTCCCT CCTCCCTCCC 1620
TCCTTCCCTC CCTCTCTGTC TTCTTGTTAA CACACTGAAA ACCCCACCCT GGAAGGCTGC 1680
AGAGAACATC CCCCTCCCCC ACCCCATGGC TGCTGTTGAG CCAGGGGATA GGGTAAGGCC 1740
TGGATTCTGC TGACGGTTCT CCCAGAGGTA GTCGGGGAGG GTGGCCTGCA AGCCCACTGG 1800
GCCCCACAGT TGTCTGCAGT CAGGCCTGTG ATCAGTCGAA TTAGAAACGA 1850